Nalirinox Neo-pancreas RAS Mut ctDNA Study

计划入组 20 人 · 首次发布于 2019 年 7 月 8 日

BELIEF (Bevacizumab and ErLotinib In EGFR Mut+ NSCLC)

计划入组 109 人 · 首次发布于 2012 年 3 月 23 日

Immunotherapy in Uncommon and 20ins EGFR-mut Lung Cancers

计划入组 627 人 · 首次发布于 2023 年 12 月 11 日

antivirulence WaaC inhibitors (Mutabilis)

FAB-001

mut-1N-IL-15/38B2

MUTAH UNIVERSITY

Jordan

Auxilio Mutuo Hospital

United States

MUTUAL PHARMACEUTICAL COMPANY, INC.

United States

Tissue TMB Outperforms Blood-Based Testing for Predicting Immunotherapy Response, Cleveland Clinic Study Confirms

Controversy Surrounds FDA Approval of Pembrolizumab for High TMB Solid Tumors

Genespire Presents Promising Dosing Data for First-in-Human Gene Therapy in Methylmalonic Acidemia